Letko Brosseau & Associates Inc. bought a new position in Moderna, Inc. (NASDAQ:MRNA – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 319,430 shares of the company’s stock, valued at approximately $31,767,000. Several other large investors also […]